Skip to content

Study of Aragvadhadi gana ghanvati (tablet) and panchkarma (mainly virechan karma) in skin disorder patients (Psoriasis)

A clinical study of Aragvadhadi gana ghanvati and virechan karma in the management of Ekakushtha w.s.r. Psoriasis

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/03/024090
Enrollment
60
Registered
2020-03-19
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L409- Psoriasis, unspecified

Interventions

Intervention1: Aragvadhadi Gana Ghanvati for internal use and Taila for local application: Dose: 1-2 gm will administered with Lukewarm water Orally for 90 days Folloup:30 days Control Intervention1:

Sponsors

Department of Kayachikitsa Shri Narayan Prasad Awasthi Govt Ayurved College Raipur CG
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients of age group between16 years to 60 years. 2.Sex- Male and Female both. 3.Symptoms mentioned in Ayurved and modern Texts

Exclusion criteria

Exclusion criteria: 1.Patients of age group below 16 years and above 60 years. 2.Pregnancy. 3.Duration of disease- more than 10 years. 4.Patients who loses their immunity power. 5.Patients of Kushtha. 6.Patients with other systemic disorders like chronic cardiac illness, tuberculosis, endocrine disorders, severe hypertension, bleeding diathesis. 7.Cancer, hepatitis, HIV.

Design outcomes

Primary

MeasureTime frame
To assess the efficacy of Aragvadhadi gana ghanvati and virechan karma in the management of PsoriasisTimepoint: 90 days or 3 months

Secondary

MeasureTime frame
As There Is Physically And Mentally Health Satisfaction So It Improves the Quality of LifeTimepoint: 90 days or 3 month

Countries

India

Contacts

Public ContactSrishti Chandrakar

Shri Narayan Prasad Awasthi Government Ayurved College Raipur Chhattisgarh

jeev.dr@gmail.com8824099797

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026